Can a traditional chinese herbal remedy stop stroke patients from getting worse?

NCT ID NCT06857487

Recruiting now Disease control Sponsor: Dongzhimen Hospital, Beijing Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a traditional Chinese herbal formula called Qingre Huatan can prevent early neurological deterioration in people who have had an acute ischemic stroke within the last 48 hours. The trial will involve 72 participants, who will receive either the herbal granules or a placebo twice daily for 10 days, alongside standard stroke care. The main goal is to see if the formula reduces the risk of worsening symptoms within the first week.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Qingre Huatan formula (herbal granules)
What this could lead to: If it works, this could offer a new way to prevent early neurological decline after a stroke, potentially reducing long-term disability.
What could go wrong: This is a small, early-phase pilot trial with only 72 participants, so results may not be conclusive. The herbal formula may not outperform placebo, and individual responses can vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE ISCHEMIC STROKE

Contacts and locations

Locations

Dongzhimen Hospital
RECRUITING

Beijing, Beijing Municipality, 100700, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.